Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-mediated SARS-CoV-2 Entry
Overview
Pharmacology
Authors
Affiliations
There is considerable variation in disease course among individuals infected with SARS-CoV-2. Many of them do not exhibit any symptoms, while some others proceed to develop COVID-19; however, severity of COVID-19 symptoms greatly differs among individuals. Focusing on the early events related to SARS-CoV-2 entry to cells through the ACE2 pathway, we describe how variability in (epi)genetic factors can conceivably explain variability in disease course. We specifically focus on variations in , and genes, as central components for SARS-CoV-2 infection, and on other molecules that modulate their expression such as , , and We propose a genetic classifier for predicting SARS-CoV-2 infectivity potential as a preliminary tool for identifying the at-risk-population. This tool can serve as a dynamic scaffold being updated and adapted to validated (epi)genetic data. Overall, the proposed approach holds potential for better personalization of COVID-19 handling.
The COVID-19 legacy: consequences for the human DNA methylome and therapeutic perspectives.
Gaetano C, Atlante S, Gottardi Zamperla M, Barbi V, Gentilini D, Illi B Geroscience. 2024; 47(1):483-501.
PMID: 39497009 PMC: 11872859. DOI: 10.1007/s11357-024-01406-7.
Devaux C, Fantini J Front Microbiol. 2023; 14:1199561.
PMID: 37520374 PMC: 10373931. DOI: 10.3389/fmicb.2023.1199561.
Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
Behura A, Naik L, Patel S, Das M, Kumar A, Mishra A Biochim Biophys Acta Mol Basis Dis. 2022; 1869(3):166634.
PMID: 36577469 PMC: 9790847. DOI: 10.1016/j.bbadis.2022.166634.
Premenopausal and postmenopausal women during the COVID-19 pandemic.
Pertynska-Marczewska M, Pertynski T Prz Menopauzalny. 2022; 21(3):200-206.
PMID: 36254124 PMC: 9551364. DOI: 10.5114/pm.2022.118695.
Clerbaux L, Albertini M, Amigo N, Beronius A, Bezemer G, Coecke S J Clin Med. 2022; 11(15).
PMID: 35956081 PMC: 9369763. DOI: 10.3390/jcm11154464.